C51.9

Case	Control
121	460084

Location	SNP	Gene	Ref>Alt	Alt in Case	Alt in Control	Chi-square	P-value	Odds Ratio
chr15:64625919	rs118166537	CSNK1G1	A>G	12	10992	30.52	3.31e-08	4.451
chr11:83047269	rs118132165	-	G>A	16	17706	30.3	3.704e-08	3.761
chr15:64315208	rs75932733	DAPK2	A>G	11	10070	28.33	1.021e-07	4.476
chr21:18245126	rs117777771	-	C>T	12	12569	25.34	4.809e-07	3.977
chr15:65035918	rs77246882	RBPMS2	C>T	11	10820	24.98	5.789e-07	4.137
chr5:4896482	rs77362329	-	C>T	19	25442	24.89	6.062e-07	3.097
chr16:12704870	rs117250380	-	G>A	13	14341	24.32	8.142e-07	3.707
chr5:175279298	rs55928437	CPLX2	T>G	13	14415	24.05	9.407e-07	3.682
chr1:203109402	rs77452745	ADORA1	G>A	13	14482	23.89	1.022e-06	3.668
chr12:80786495	rs116998753	-	T>C	17	22209	23.32	1.374e-06	3.157
chr7:137917113	rs2254773	-	C>G	21	30597	23.12	1.523e-06	2.853
chr19:51834004	rs3887787	-	T>C	43	86354	23.09	1.549e-06	2.197
chr13:29229869	rs117915761	-	C>T	26	42055	22.73	1.864e-06	2.591
chr8:31516716	rs77828056	NRG1	G>A	20	28756	22.7	1.896e-06	2.889
chr16:81193358	rs59878884	-	C>G	18	24626	22.56	2.037e-06	3.021
chr3:23136580	rs76343649	-	C>T	11	11653	22.35	2.275e-06	3.87
chr11:83613699	rs79351761	DLG2	G>A	12	13605	21.96	2.78e-06	3.657
chr22:33672085	rs79223970	LARGE1	C>T	25	40519	21.87	2.923e-06	2.587
chr5:134442190	rs78013559	-	G>A	21	31678	21.48	3.575e-06	2.755
chr14:89928352	rs17798897	FOXN3	C>T	12	13595	21.38	3.773e-06	3.595
chr15:64625919	rs118166537	CSNK1G1	A>G	12	10841	29.52	5.543e-08	4.362
chr11:83047269	rs118132165	-	G>A	16	17396	29.42	5.821e-08	3.702
chr16:81193358	rs59878884	-	C>G	18	21179	28.32	1.03e-07	3.408
chr15:64315208	rs75932733	DAPK2	A>G	11	9908	27.52	1.553e-07	4.398
chr21:18245126	rs117777771	-	C>T	12	12368	24.64	6.898e-07	3.915
chr12:47393719	rs7294950	-	G>A	10	9230	24.34	8.056e-07	4.312
chr5:4896482	rs77362329	-	C>T	19	24943	24.17	8.801e-07	3.054
chr15:65035918	rs77246882	RBPMS2	C>T	11	10682	24.09	9.179e-07	4.05
chr16:12704870	rs117250380	-	G>A	13	14148	23.46	1.278e-06	3.633
chr1:203109402	rs77452745	ADORA1	G>A	13	14218	23.21	1.453e-06	3.611
chr5:175279298	rs55928437	CPLX2	T>G	13	14237	23.12	1.524e-06	3.603
chr19:51834004	rs3887787	-	T>C	41	77496	23.12	1.524e-06	2.232
chr7:137917113	rs2254773	-	C>G	21	29804	22.72	1.877e-06	2.832
chr12:80786495	rs116998753	-	T>C	17	21804	22.59	2.009e-06	3.108
chr23:139949563	rs7882637	-	G>A	84	357469	22.46	2.15e-06	0.5317
chr8:31516716	rs77828056	NRG1	G>A	20	28127	22.11	2.572e-06	2.856
chr8:2545359	rs58330228	-	C>A	17	22211	21.78	3.057e-06	3.051
chr3:23136580	rs76343649	-	C>T	11	11432	21.77	3.075e-06	3.814
chr2:187441832	rs76405227	-	G>T	12	13026	21.63	3.298e-06	3.623
chr9:113908189	rs72759341	-	A>G	14	16659	21.29	3.94e-06	3.314

Location

SNP

Gene

Ref>Alt

Alt in Case

Alt in Control

Chi-square

P-value

Odds Ratio

chr15:64625919

rs118166537

CSNK1G1

A>G

12

10992

30.52

3.31e-08

4.451

chr11:83047269

rs118132165

-

G>A

16

17706

30.3

3.704e-08

3.761

chr15:64315208

rs75932733

DAPK2

A>G

11

10070

28.33

1.021e-07

4.476

chr21:18245126

rs117777771

-

C>T

12

12569

25.34

4.809e-07

3.977

chr15:65035918

rs77246882

RBPMS2

C>T

11

10820

24.98

5.789e-07

4.137

chr5:4896482

rs77362329

-

C>T

19

25442

24.89

6.062e-07

3.097

chr16:12704870

rs117250380

-

G>A

13

14341

24.32

8.142e-07

3.707

chr5:175279298

rs55928437

CPLX2

T>G

13

14415

24.05

9.407e-07

3.682

chr1:203109402

rs77452745

ADORA1

G>A

13

14482

23.89

1.022e-06

3.668

chr12:80786495

rs116998753

-

T>C

17

22209

23.32

1.374e-06

3.157

chr7:137917113

rs2254773

-

C>G

21

30597

23.12

1.523e-06

2.853

chr19:51834004

rs3887787

-

T>C

43

86354

23.09

1.549e-06

2.197

chr13:29229869

rs117915761

-

C>T

26

42055

22.73

1.864e-06

2.591

chr8:31516716

rs77828056

NRG1

G>A

20

28756

22.7

1.896e-06

2.889

chr16:81193358

rs59878884

-

C>G

18

24626

22.56

2.037e-06

3.021

chr3:23136580

rs76343649

-

C>T

11

11653

22.35

2.275e-06

3.87

chr11:83613699

rs79351761

DLG2

G>A

12

13605

21.96

2.78e-06

3.657

chr22:33672085

rs79223970

LARGE1

C>T

25

40519

21.87

2.923e-06

2.587

chr5:134442190

rs78013559

-

G>A

21

31678

21.48

3.575e-06

2.755

chr14:89928352

rs17798897

FOXN3

C>T

12

13595

21.38

3.773e-06

3.595

chr15:64625919

rs118166537

CSNK1G1

A>G

12

10841

29.52

5.543e-08

4.362

chr11:83047269

rs118132165

-

G>A

16

17396

29.42

5.821e-08

3.702

chr16:81193358

rs59878884

-

C>G

18

21179

28.32

1.03e-07

3.408

chr15:64315208

rs75932733

DAPK2

A>G

11

9908

27.52

1.553e-07

4.398

chr21:18245126

rs117777771

-

C>T

12

12368

24.64

6.898e-07

3.915

chr12:47393719

rs7294950

-

G>A

10

9230

24.34

8.056e-07

4.312

chr5:4896482

rs77362329

-

C>T

19

24943

24.17

8.801e-07

3.054

chr15:65035918

rs77246882

RBPMS2

C>T

11

10682

24.09

9.179e-07

4.05

chr16:12704870

rs117250380

-

G>A

13

14148

23.46

1.278e-06

3.633

chr1:203109402

rs77452745

ADORA1

G>A

13

14218

23.21

1.453e-06

3.611

chr5:175279298

rs55928437

CPLX2

T>G

13

14237

23.12

1.524e-06

3.603

chr19:51834004

rs3887787

-

T>C

41

77496

23.12

1.524e-06

2.232

chr7:137917113

rs2254773

-

C>G

21

29804

22.72

1.877e-06

2.832

chr12:80786495

rs116998753

-

T>C

17

21804

22.59

2.009e-06

3.108

chr23:139949563

rs7882637

-

G>A

84

357469

22.46

2.15e-06

0.5317

chr8:31516716

rs77828056

NRG1

G>A

20

28127

22.11

2.572e-06

2.856

chr8:2545359

rs58330228

-

C>A

17

22211

21.78

3.057e-06

3.051

chr3:23136580

rs76343649

-

C>T

11

11432

21.77

3.075e-06

3.814

chr2:187441832

rs76405227

-

G>T

12

13026

21.63

3.298e-06

3.623

chr9:113908189

rs72759341

-

A>G

14

16659

21.29

3.94e-06

3.314

ID	Name	Top Correlation
HP: 0000055	Abnormality of female external genitalia	0/20
HP: 0000058	Abnormality of the labia	0/20
HP: 0000078	Abnormality of the genital system	0/20
HP: 0000118	Phenotypic abnormality	0/20
HP: 0000119	Abnormality of the genitourinary system	0/20
HP: 0000811	Abnormal external genitalia	0/20
HP: 0000951	Abnormality of the skin	0/20
HP: 0001028	Hemangioma	0/20
HP: 0001574	Abnormality of the integument	0/20
HP: 0001626	Abnormality of the cardiovascular system	0/20
HP: 0002597	Abnormality of the vasculature	0/20
HP: 0002664	Neoplasm	0/20
HP: 0007379	Neoplasm of the genitourinary tract	0/20
HP: 0010460	Abnormality of the female genitalia	0/20
HP: 0010787	Genital neoplasm	0/20
HP: 0011121	Abnormality of skin morphology	0/20
HP: 0011793	Neoplasm by anatomical site	0/20
HP: 0012243	Abnormal reproductive system morphology	0/20
HP: 0012881	Abnormality of the labia majora	0/20
HP: 0012882	Hyperplastic labia majora	0/20
HP: 0030416	Vulvar neoplasm	0/20
HP: 0030417	Squamous cell carcinoma of the vulva	0/20
HP: 0030418	Vulvar melanoma	0/20
HP: 0030420	Vulvar adenocarcinoma	0/20
HP: 0032202	Vulvar intraepithelial neoplasia	0/20
HP: 0100742	Vascular neoplasm	0/20
HP: 0410272	Vulvar hemangioma	0/20

Vulva, unspecified

C51.9

Case/Control GWAS ^ⓘ

Links

Statistics

Top SNP Information

Associated Phenotypes ^ⓘ

Vulva, unspecified

C51.9

Case/Control GWAS ⓘ

Links

Statistics

Top SNP Information Show Table

Associated Phenotypes ⓘ Shared SNP phenotypes No shared SNP phenotypes

Case/Control GWAS ^ⓘ

Top SNP Information

Associated Phenotypes ^ⓘ